The surgeon who operated on a teenage girl in Italy, who became unwell and died after getting the COVID-19 vaccine, was taken aback by what he discovered.

Dr. Gianluigi Zona, head of Genoa’s San Martino general hospital’s neurosurgery and brain trauma unit, said Camilla Canepa, 18, had major blood clotting in her brain and died of a cerebral hemorrhage.

The surgeon stated that he had “never seen a brain reduced in these settings by a thrombosis so extensive and so serious.”

“All the venous sinuses were blocked by thrombus [blood clots], a scenario which I have never seen in all my years in this profession,” Zona said.

“You must picture the venous sinus as a river in the middle of a valley in which many different streams converge,” he continued.

“If you build a dam at the center of the watercourse, the river swells and at that point the tributaries aren’t able to run, with the result that the upstream pressure rises,” he said, as reported by LifeSite.

In addition, Zona claimed he wasn’t a virologist, epidemiologist, or coroner, but he sensed something was wrong.

“Considering what I saw in that girl’s head, it’s clear that we are facing something not normal.”

On May 25, Canepa was given the AstraZeneca vaccine at a vaccination “open day” for young persons over 18.

The inoculation events were frequently organized during evenings and weekends. According to Reuters, they were partly geared at avoiding AstraZeneca doses from going to waste amid numerous complaints of older individuals rejecting the medicine and canceling their immunization appointments.

After two CT scans at a hospital in Lavagna, near Genoa, Canepa was moved to the clinic at 5 a.m. on June 6.

According to the Italian Il Piccolo newspaper, the first scan, performed on June 3 when the girl originally went to the hospital complaining of terrible headaches, did not reveal the blood clots.

The second scan, performed shortly after the girl returned to the hospital late on the night of June 5, led to Camilla’s immediate transfer to San Martino.

The on-call neurosurgeon and the chief physician worked side by side at the operating table to treat her.

Doctors diagnosed her with familial autoimmune thrombocytopenia, a rare bleeding illness, but her parents insist she “had no disease.”

Italy has banned the use of the AstraZeneca vaccination for persons under the age of 60 as a result of Camilla’s death, reported Reuters.

Her death also sparked a media and political uproar over the Anglo-Swedish company’s shot being used for adults of all ages despite medical concerns highlighted previously.

“AstraZeneca will only be used for people over 60,” the country’s special COVID commissioner Francesco Figliuolo told reporters.

“The risk-benefit assessment has changed,” Locatelli said, without mentioning the death of Canepa, who suffered from a low platelet count, brain haemorrhage and abdominal blood clots.

In March, Italy, like several other European countries, temporarily ceased AstraZeneca vaccinations due to concerns about rare blood clotting disorders, mostly in young people.

After the European medicines agency concluded the benefits of the jab outweighed the hazards, it resumed them the following month with the recommendation that the vaccine be ideally used for those over 60.

However, as Mario Draghi’s government wanted to ratchet up its immunization campaign, certain Italian areas held “open days” where the AstraZeneca vaccine was given to anybody aged 18 and older.